Search - tctmd.com

Displaying 421 - 440 of 2624

Sort: Relevancy | Date

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

L.A. McKeown

February 21, 2016

News Daily News

COAST II: Los Stents Recubiertos son Prometedores en Pacientes con Patologías Aórticas Congénitas Raras

L.A. McKeown

February 21, 2016

$Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis$

Presentation JIM 2016

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

Presenter: Paolo Pagnotta

February 12, 2016

Presentation JIM 2016

The Lotus Valve: Simplifying Real World Practice

Presenter: Raul Moreno

February 11, 2016

Presentation JIM 2016

Filter Science: The Use Of Cerebral Protection To Prevent Irreversible Cerebral Infarction During Contemporary TAVI Procedures

Presenter: Azeem Latib

February 11, 2016

Presentation JIM 2016

PORTICO™ transcatheter aortic heart valve: elegant technology drives optimal clinical outcomes

Presenter: Francesco Bedogni

February 10, 2016

Presentation JIM 2016

Patient specific TAVI simulationsToday and tomorrow

Presenter: Azeem Latib

February 10, 2016

Presentation JIM 2016

Lithoplasty for Aortic Leaflet Restoration

Presenter: Todd J. Brinton

February 10, 2016

Presentation JIM 2016

CoreValve Evolut R: Setting New Standards in TAVI Without Compromise

Presenter: Ganesh Manoharan

February 10, 2016

Presentation JIM 2016

ACURATE Neo: Top-down deployment translates into stable, precise positioning and successful procedures: Symetis TAVI programme highlights

Presenter: Christian Hengstenberg

February 10, 2016

Presentation JIM 2016

SAPIEN 3: Current Experience

Presenter: Martin B. Leon

February 09, 2016

News Daily News

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Michael O'Riordan

February 08, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

Michael O'Riordan

February 08, 2016

News Daily News

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

L.A. McKeown

February 07, 2016

News Daily News

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

L.A. McKeown

February 07, 2016

Presentation

Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After TAVR

Presenter: M. Del Trigo

February 07, 2016

Presentation ISET 2016

Extreme TAVR: What Are the Limits and the Future?

Presenter: Eberhard Grube

February 06, 2016

Presentation ISET 2016

Current Indications for TAVR Therapy: Are They Different in the United States and Europe?

Presenter: Eberhard Grube

February 06, 2016

Advertisement

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Covered Stents Show Promise in Patients With Aortic Coarctation: COAST II

COAST II: Los Stents Recubiertos son Prometedores en Pacientes con Patologías Aórticas Congénitas Raras

Successful Symetis ACURATE neo valve implantation in a elderly patient with low ejection fraction low-gradient aortic stenosis

The Lotus Valve: Simplifying Real World Practice

Filter Science: The Use Of Cerebral Protection To Prevent Irreversible Cerebral Infarction During Contemporary TAVI Procedures

PORTICO™ transcatheter aortic heart valve: elegant technology drives optimal clinical outcomes

Patient specific TAVI simulationsToday and tomorrow

Lithoplasty for Aortic Leaflet Restoration

CoreValve Evolut R: Setting New Standards in TAVI Without Compromise

ACURATE Neo: Top-down deployment translates into stable, precise positioning and successful procedures: Symetis TAVI programme highlights

SAPIEN 3: Current Experience

在 TAVR 患者中观察到瓣膜血流动力学的亚临床变化

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Se Observan Cambios Subclínicos en la Hemodinámica Valvular en Pacientes TAVR

研究确定患者使用 Sapien 3 出现新传导异常、需要心脏起搏器置入的预测因素

Study Pinpoints Predictors of New Conduction Abnormalities, Pacemaker With Sapien 3

Incidence, Timing, and Predictors of Valve Hemodynamic Deterioration After TAVR

Extreme TAVR: What Are the Limits and the Future?

Current Indications for TAVR Therapy: Are They Different in the United States and Europe?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content